We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

318 hedge funds and large institutions have $5.19B invested in Exact Sciences in 2017 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 89 increasing their positions, 127 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

168% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 22

13% more funds holding

Funds holding: 282318 (+36)

10% more capital invested

Capital invested by funds: $4.71B → $5.19B (+$481M)

1.01% less ownership

Funds ownership: 83.88%82.87% (-1%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

30% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 127

78% less call options, than puts

Call options by funds: $93.8M | Put options by funds: $422M

Holders
318
Holders Change
+36
Holders Change %
+12.77%
% of All Funds
7.21%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
59
Increased
89
Reduced
127
Closed
22
Calls
$93.8M
Puts
$422M
Net Calls
-$328M
Net Calls Change
-$82.8M
Name Holding Trade Value Shares
Change
Change in
Stake
MPWT
201
MassMutual Private Wealth & Trust
Connecticut
$527K +$1.66K +31 +0.3%
AIP
202
Ameritas Investment Partners
Nebraska
$526K +$30.2K +565 +6%
IP
203
Intellectus Partners
California
$525K
MIA
204
MainStreet Investment Advisors
Illinois
$525K +$534K +10,000 New
PG
205
PEAK6 Group
Illinois
$519K +$527K +9,870 New
MML Investors Services
206
MML Investors Services
Massachusetts
$498K +$185K +3,467 +58%
Two Sigma Investments
207
Two Sigma Investments
New York
$492K +$500K +9,366 New
SM
208
Southport Management
Wyoming
$473K -$320K -6,000 -40%
GG
209
Gofen & Glossberg
Illinois
$473K -$10.7K -200 -2%
SCM
210
Shelton Capital Management
Colorado
$462K
KeyBank National Association
211
KeyBank National Association
Ohio
$458K -$159K -2,973 -25%
Simplex Trading
212
Simplex Trading
Illinois
$458K +$224K +4,201 +93%
GWM
213
Geneos Wealth Management
Colorado
$424K -$9.45K -177 -2%
LTFS
214
Ladenburg Thalmann Financial Services
Florida
$424K +$70.2K +1,315 +20%
FWP
215
FAS Wealth Partners
Kansas
$420K -$107K -2,000 -20%
BKA
216
Brick & Kyle Associates
Pennsylvania
$407K -$13.3K -250 -3%
SBIA
217
Sheaff Brock Investment Advisors
Indiana
$405K -$53.4K -1,000 -11%
MGIA
218
Moneta Group Investment Advisors
Missouri
$385K +$31.6K +592 +9%
HSBC Holdings
219
HSBC Holdings
United Kingdom
$383K -$1.6K -30 -0.4%
LCM
220
Legato Capital Management
California
$377K
Zurich Cantonal Bank
221
Zurich Cantonal Bank
Switzerland
$375K +$111K +2,085 +41%
AIA
222
Affinity Investment Advisors
California
$373K -$154K -2,883 -29%
Allianz Asset Management
223
Allianz Asset Management
Germany
$364K -$7.22M -135,266 -95%
FBFS
224
First Business Financial Services
Wisconsin
$359K
AMG
225
Advisors Management Group
Wisconsin
$354K

EXAS Hedge Fund Activity: Q4 2017 in Review

318 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2017, worth a combined $5.19B — up 10% from $4.71B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new EXAS positions and 22 closed out — a net gain of 37 holders — while 89 added to existing stakes and 127 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $100M. The largest seller was William Blair Investment Management, cutting an estimated $52.6M.

  • 318 institutional investors held Exact Sciences (EXAS) as of Q4 2017, up from 282 in Q3 2017.
  • Funds reported $5.19B of Exact Sciences stock for Q4 2017, up 10% quarter-over-quarter.
  • 59 funds opened new Exact Sciences positions in Q4 2017 and 22 closed out, a net change of +37 holders.
  • The largest Exact Sciences buyer in Q4 2017 was Wellington Management Group, an estimated $100M added.
  • The largest Exact Sciences seller in Q4 2017 was William Blair Investment Management, an estimated $52.6M sold.

Based on aggregated 13F filings for Q4 2017.